Laryngeal Kaposi's Sarcoma Complicated by the Immune Reconstitution Inflammatory Syndrome in an HIV-infected Patient

Intern Med. 2016;55(8):1001-5. doi: 10.2169/internalmedicine.55.5813. Epub 2016 Apr 15.

Abstract

We herein report a case of laryngeal Kaposi's sarcoma (KS) complicated by immune reconstitution inflammatory syndrome in a human immunodeficiency virus (HIV)-infected patient. The patient initially presented with KS involving the larynx, which was successfully treated with pegylated liposomal doxorubicin (PLD) and antiretroviral therapy (ART). PLD was discontinued after 2 courses because of a marked clinical improvement; however, the patient experienced progressive odynophagia and dyspnea 2 months after the initiation of ART. Laryngoscopy revealed a severely swollen, inflamed epiglottis. The readministration of PLD was successful, and the patient was thereafter discharged without any subsequent complications.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Doxorubicin / analogs & derivatives
  • Doxorubicin / therapeutic use
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Humans
  • Immune Reconstitution Inflammatory Syndrome / drug therapy
  • Immune Reconstitution Inflammatory Syndrome / etiology*
  • Laryngeal Neoplasms / drug therapy
  • Laryngeal Neoplasms / etiology*
  • Male
  • Polyethylene Glycols / therapeutic use
  • Sarcoma, Kaposi / drug therapy
  • Sarcoma, Kaposi / etiology*

Substances

  • Anti-Retroviral Agents
  • Antineoplastic Agents
  • liposomal doxorubicin
  • Polyethylene Glycols
  • Doxorubicin